125 related articles for article (PubMed ID: 15127718)
21. Addition of an IL-15 mutant/FCgamma2A antagonist protein protects islet allografts from rejection overriding costimulation blockade.
Ferrari-Lacraz S; Zheng XX; Kim YS; Maslinski W; Strom TB
Transplant Proc; 2002 May; 34(3):745-7. PubMed ID: 12034169
[No Abstract] [Full Text] [Related]
22. RCAN-11R peptide provides immunosuppression for fully mismatched islet allografts in mice.
Noguchi H; Sugimoto K; Miyagi-Shiohira C; Nakashima Y; Kobayashi N; Saitoh I; Watanabe M; Noguchi Y
Sci Rep; 2017 Jun; 7(1):3043. PubMed ID: 28596584
[TBL] [Abstract][Full Text] [Related]
23. Diabetogenic synergism in canine islet autografts from cyclosporine and steroids in combination.
Shapiro AM; Hao E; Lakey JR; Finegood D; Rajotte RV; Kneteman NM
Transplant Proc; 1998 Mar; 30(2):527. PubMed ID: 9532162
[No Abstract] [Full Text] [Related]
24. Immunosuppression for islet transplantation.
Noguchi H; Matsumoto S; Matsushita M; Kobayashi N; Tanaka K; Matsui H; Tanaka N
Acta Med Okayama; 2006 Apr; 60(2):71-6. PubMed ID: 16680182
[TBL] [Abstract][Full Text] [Related]
25. T-cell-directed immunosuppression allows prolonged survival of xenogeneic pig islets in monkeys.
Jonker M; Rijkelijkhuizen JK; Haanstra KG; Kuhn EM; Ringers J; Bouwman E
Transplant Proc; 2001; 33(1-2):726. PubMed ID: 11267041
[No Abstract] [Full Text] [Related]
26. Liver allograft fibrosis and minimization of immunosuppression.
Ranganathan S; Celik N; Mazariegos G; Sindhi R
Pediatr Transplant; 2015 Nov; 19(7):667-8. PubMed ID: 26333572
[No Abstract] [Full Text] [Related]
27. Deoxyspergualin--a different and intriguing immunosuppressant.
Tufveson G; Gannedahl G
Transplant Proc; 1994 Oct; 26(5):3029-39. PubMed ID: 7940954
[No Abstract] [Full Text] [Related]
28. Immunosuppressive therapies after heart transplantation--The balance between under- and over-immunosuppression.
Söderlund C; Rådegran G
Transplant Rev (Orlando); 2015 Jul; 29(3):181-9. PubMed ID: 25812489
[TBL] [Abstract][Full Text] [Related]
29. Glucocorticoids inhibit calcium- and calcineurin-dependent activation of the human IL-4 promoter.
Chen R; Burke TF; Cumberland JE; Brummet M; Beck LA; Casolaro V; Georas SN
J Immunol; 2000 Jan; 164(2):825-32. PubMed ID: 10623828
[TBL] [Abstract][Full Text] [Related]
30. Immunosuppression with cyclosporin A in combination with leflunomide and mycophenolate mofetil prevents rejection of pig-islets transplanted into rats.
Wennberg L; Wallgren AC; Sundberg B; Rafael E; Zhu S; Liu J; Tibell A; Karlsson-Parra A; Groth CG; Korsgren O
Transplant Proc; 1996 Apr; 28(2):819. PubMed ID: 8623416
[No Abstract] [Full Text] [Related]
31. Immunological risks of minimization strategies.
Snanoudj R; Tinel C; Legendre C
Transpl Int; 2015 Aug; 28(8):901-10. PubMed ID: 25809144
[TBL] [Abstract][Full Text] [Related]
32. Low energy X-ray (grenz ray) treatment of purified islets prior to allotransplant markedly decreases passenger leukocyte populations.
Pawlick R; Gala-Lopez B; Pepper AR; Abualhassan N; Bruni A; Suzuki K; Rayat G; Elliott JF; Shapiro AMJ
Islets; 2017 Jul; 9(4):e1330742. PubMed ID: 28692319
[TBL] [Abstract][Full Text] [Related]
33. Predictive factors of allosensitization after immunosuppressant withdrawal in recipients of long-term cultured islet cell grafts.
Hilbrands R; Gillard P; Van der Torren CR; Ling Z; Verheyden S; Jacobs-Tulleneers-Thevissen D; Roep BO; Claas FH; Demanet C; Gorus FK; Pipeleers D; Keymeulen B
Transplantation; 2013 Jul; 96(2):162-9. PubMed ID: 23857001
[TBL] [Abstract][Full Text] [Related]
34. Efficacy of various immunosuppressive drugs in preventing pig-to-rat islet xenograft rejection.
Wennberg L; Wallgren AC; Karlsson-Parra A; Kozlowski T; Sundberg B; Tibell A; Groth CG; Korsgren O
Transplant Proc; 1995 Feb; 27(1):266-7. PubMed ID: 7533391
[No Abstract] [Full Text] [Related]
35. Leflunomide and its analogue X920715 synergize with cyclosporin A in preventing early graft failure and delaying graft rejection of xenogeneic islets in nonobese diabetic mice.
Gysemans C; Waer M; Laureys J; Bouillon R; Mathieu C
Transplant Proc; 2001 May; 33(3):2094-5. PubMed ID: 11377464
[No Abstract] [Full Text] [Related]
36. An update on chemical pharmacotherapy options for the prevention of kidney transplant rejection with a focus on costimulation blockade.
Kälble F; Schaier M; Schäfer S; Süsal C; Zeier M; Sommerer C; Morath C
Expert Opin Pharmacother; 2017 Jun; 18(8):799-807. PubMed ID: 28460546
[TBL] [Abstract][Full Text] [Related]
37. [Immunosuppressive drugs and calcineurin].
Masugi T; Otsuka K
Tanpakushitsu Kakusan Koso; 1998 Sep; 43(12 Suppl):1739-43. PubMed ID: 9788176
[No Abstract] [Full Text] [Related]
38. Outlook for longer-lasting islets.
Wood K
Nat Med; 2008 Nov; 14(11):1156-7. PubMed ID: 18989281
[No Abstract] [Full Text] [Related]
39. Pravastatin and low-dose cyclosporine treatment prevent islet allograft rejection in mice.
Arita S; Kasraie A; Une S; Ohtsuka S; Atiya A; Shevlin L; Mullen Y
Transplant Proc; 1998 Mar; 30(2):522. PubMed ID: 9532158
[No Abstract] [Full Text] [Related]
40. Tacrolimus dosing in mycophenolate-treated patients--can we get away with less?
de Fijter JW
Transplantation; 2011 Jul; 92(1):10-1. PubMed ID: 21654351
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
